Oral dialysis treatment composition for chronic and end-stage renal disease patients

摘要

The present invention relates to an oral therapeutic composition comprising mannitol as a main component, which is effective for the treatment of chronic and end-stage renal disease patients.;15 to 30 parts by weight of mannitol as a nonabsorbent agent, 2 to 3 parts by weight of NaCl,₂SO₄4.5 to 5.5 parts by weight, KCl 0.7 to 0.8 parts by weight, NaHCO₃1 to 2 parts by weight. The composition is dissolved in 1 liter of water and taken four times a day, thereby remarkably eliminating the poisonous substance of the patient.;The therapeutic effect of the therapeutic composition for oral use of the present invention is the same as the treatment of hemodialysis or peritoneal dialysis for 12 hours a week (three times a week for 4 hours) in renal failure patients.